Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
The ShariaPortfolio Group Of Companies Surpasses $1 Billion in Assets Under Management
-
Hapbee Received Commitments for $2.785 Million From Qualified Investors
-
Invesco Ltd: Form 8.3 - International Paper company
-
Invesco Ltd: Form 8.3 - Mondi PLC
-
Landsbankinn hf.: Annual General Meeting 19 April 2024
-
Medicovestor Selected as Finalist to Present Its First-in-Class ADC Platforms at JP Morgan Asset Management: Life Sciences Innovation Summit
-
HiberCell Announces Recent Publication and Poster Presentations for its Novel GCN2 Activator, HC-7366
-
TESSAN Introduces the Future of Travel Charging: A World Adapter with Gan Technology
-
Tunnel to Towers Foundation Delivers Mortgage-Free Homes to Five Gold Star Families
-
NMSDC Announces 2024 Emerging Young Entrepreneurs
-
Subsea 7 S.A. notification of major holding
-
Increase the authorized capital of VILVI GROUP subsidiary SIA "Baltic Dairy Board"
-
New Board Candidate for the upcoming Annual Geneal Meeting
-
Draft decisions of the Annual General Meeting of Shareholders to be held on 26 April 2024
-
Vantiva - March 2024 - Information concerning the total number of voting rights and shares
-
Dan Strömberg resigns from the Board of Telia Lietuva
-
Safety Shot Closes $5 Million No Warrant Private Placement Priced At-the-Market
-
Innovative Outcomes (OTC:UBQU) Announces Distribution Agreement With MDM Wound Ventures to Distribute New EZE Debride System to Healthcare Professionals in 4.95 Billion Dollar Market
-
LIS Technologies Inc. Establishes Corporate Affiliation with the Nuclear Institute
-
Notice of the Annual General Meeting of Shareholders on 26 April 2024
-
NGM Bio Announces Closing of Tender Offer
-
Bestqool Launches Innovative Red Light Therapy Devices for Eczema Relief
-
The Board approved financial statements for the year 2023 and proposes to pay 0.09 euro dividend per share for the year 2023
-
US Gastroenterologists Project Swift Uptake of Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
-
Diana Shipping Inc. Announces the Filing of Its 2023 Annual Report on Form 20-F
-
Univest Financial Corporation to Hold First Quarter 2024 Earnings Call
-
Progress Software Corp. Announcement under the Irish Takeover Rules
-
Eagle Shareholders Approve Merger With Star Bulk
-
0180791 B.C. LTD. COMPLETES PLAN OF ARRANGEMENT
-
Praxis Precision Medicines to Participate in Upcoming April Conferences
-
MoneyHero Group to Announce Fourth Quarter and Full Year 2023 Results
-
IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries
-
eXp Realty Names Leo Pareja as CEO to Drive Next Era of Growth and Innovation
-
Pittsburgh Post-Gazette Features One of Zefiro Methane’s Subsidiaries in an Article on Orphaned Wells in Pennsylvania
-
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer
-
Finacity Facilitates the Upsize and Renewal of a $250 Million IFRS Off-Balance Sheet Securitization for Votorantim Cimentos North America
-
WTW to Announce First Quarter Earnings on April 25, 2024
-
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
-
Avance Gas Holding Ltd: Annual Report and ESG Report 2023
-
First Western Financial, Inc. to Report First Quarter 2024 Financial Results on Thursday, April 18
-
SEALSQ Announces Launch Date of Revolutionary Hybrid Payment & Utility Token, SEALCOIN
-
Alliance Trust PLC - Net Asset Value
-
SEALSQ Announces Launch Date of Revolutionary Hybrid Payment & Utility Token, SEALCOIN
-
Navios Maritime Partners L.P. Announces Availability of Its Form 20-F for the Year Ended December 31, 2023
-
Issue of Equity
-
KopenTech Achieves Milestone with Successful SOC 2 Type II Audit Certification
-
CEMATRIX To Report Fourth Quarter and 2023 Year End Results On April 10, 2024
-
Firan Technology Group Corporation (“FTG”) Announces First Quarter 2024 Earnings Release and Conference Call Dates
-
IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
-
Midland States Bancorp, Inc. To Announce First Quarter 2024 Financial Results on Thursday, April 25
